Anti-Aging · Reference
Sermorelin for Men: What the Trials in Older Men Actually Found
This page covers what sermorelin is, what research has and has not looked at in men, how it relates to sleep and the growth hormone decline after 40, testosterone and TRT, the considerations that matter for men, and how Pepti supplies it. For the general evidence, see sermorelin benefits; for the full reference, what is sermorelin.

Much of sermorelin's adult evidence was gathered in older men, and it consistently shows one thing: a GHRH(1-29) dose raises a man's own nocturnal growth hormone, and with enough dosing it raises IGF-1. In a 1997 placebo-controlled trial in adults aged 55 to 71, the increases in lean mass and insulin sensitivity were seen in men only, alongside better self-rated well-being and libido, with no change in sleep quality; a separate six-week trial in eleven older men found no change in body composition. Sermorelin is not a testosterone booster and does not treat low testosterone. Compounded sermorelin is not FDA approved.
This page covers what sermorelin is, what research has and has not looked at in men, how it relates to sleep and the growth hormone decline after 40, testosterone and TRT, the considerations that matter for men, and how Pepti supplies it. For the general evidence, see sermorelin benefits; for the full reference, what is sermorelin.
Sermorelin for Men
The short answer
| Question | What the live research shows | Strength of evidence |
|---|---|---|
| Does it raise growth hormone in men? | Yes; nocturnal growth hormone rose in every trial in older men | Human, small |
| Does it raise IGF-1 in men? | At the higher of two twice-daily doses (1992) and on nightly dosing for 16 weeks (1997); not on single nightly injections for six weeks (1997) | Human, small, dose-dependent |
| Lean mass | Increased in men in the 16-week trial; unchanged in the six-week trial | Mixed and small |
| Insulin sensitivity | Rose in men in the 16-week trial | Single small trial |
| Strength | Better on a minority of measures in the six-week trial | Weak |
| Well-being and libido | Self-rated as better in men in the 16-week trial | Single small trial, self-report |
| Sleep | Sleep quality unchanged where measured; a short-acting GHRH did not improve measured sleep | Reported by patients, not demonstrated |
| Testosterone | Not raised; sermorelin acts on a separate axis | Not a testosterone booster |
The short version: the hormonal effect in men is well documented; the body-composition and well-being changes come from one small trial and were not repeated.
Sermorelin for Men
What sermorelin is, in one paragraph
Sermorelin is the first 29 of the 44 amino acids of growth-hormone-releasing hormone (GHRH), the signal the hypothalamus sends to the pituitary. The 1999 BioDrugs review describes it as the shortest synthetic fragment of GHRH with full biological activity. It binds the GHRH receptor on the cells that make growth hormone and triggers release of what they have stored, in a pulse, with the body's feedback controls, somatostatin and IGF-1, still working. It contains no growth hormone, is not a steroid, and does not act on the testes or the testosterone axis. It was the active ingredient of an FDA-approved drug for children, approved in 1990 and 1997 and discontinued in 2008; in 2013 the FDA determined the withdrawal was not for reasons of safety or effectiveness.
Sermorelin for Men
Why men ask about it after 40
Growth hormone pulses shrink, and body fat shrinks them further
Growth hormone is released in bursts, the largest during deep sleep. In healthy men sampled around the clock, daily secretion fell by roughly 14 percent per decade, and at any given age each extra unit of body mass index cut it by a further 6 percent or so (Journal of Clinical Endocrinology and Metabolism, 1991). That is the logic behind GHRH analogues such as sermorelin: they ask the pituitary for a larger pulse rather than supplying the hormone.
Deep sleep falls in midlife and takes the largest pulse with it
A pooled analysis of 149 healthy men aged 16 to 83, published in JAMA in 2000, found deep slow-wave sleep falling from about 19 percent of the night in early adulthood to about 3 percent by ages 36 to 50, with a parallel fall in growth hormone secretion. Independent of age, growth hormone output tracked the amount of slow-wave sleep. That is why sermorelin is dosed at bedtime: to add to the pulse that arrives in deep sleep. It is a mechanistic rationale, not a trial result.
Sermorelin for Men
What research has looked at in men
The 1992 National Institute on Aging study
Healthy older men were given GHRH(1-29) twice daily for fourteen days at two doses. IGF-1 rose into the young-adult range only at the higher dose, and the amplitude of growth hormone peaks rose toward that of young men while the pulsatile pattern stayed intact.
What it shows. The older male pituitary still responds to a GHRH signal, and the pattern of release stays physiological.
What it does not show. Anything about body composition, strength or how men felt. It ran for two weeks and measured hormones.
The 1997 Johns Hopkins trial
Eleven healthy men aged 64 to 76 received single nightly injections for six weeks (Metabolism, 1997). Nocturnal growth hormone rose, and some strength and endurance measures were reported as better, but IGF-1, body composition, weight, glucose and lipids did not change. The authors concluded that a single nightly dose was less effective than multiple daily doses at producing IGF-1-mediated effects.
What it shows. That schedule matters: a rise in growth hormone without a rise in IGF-1 did not translate into body-composition change in six weeks.
The 1997 UC San Diego trial
The most detailed adult trial, and the only one in the live research that reported men and women separately. Nine men and ten women aged 55 to 71 self-injected placebo nightly for four weeks, then a closely related GHRH(1-29) analogue nightly for sixteen weeks (Journal of Clinical Endocrinology and Metabolism, 1997).
Outcome Men Women Nocturnal growth hormone Rose Rose IGF-1 Rose Rose Skin thickness Increased Increased Lean body mass Increased Not reported as increased Insulin sensitivity Rose Not reported as increased Self-rated well-being and libido Better Not reported as better Sleep quality Unchanged Unchanged Fasting glucose and insulin Unaltered Unaltered IGF-1 rose within two weeks, stayed elevated for twelve, then drifted toward baseline by sixteen. The only adverse effect recorded was a transient lipid rise that resolved by the end of the study.
What it shows. In this trial, men had more of a body-composition and metabolic response than women.
What it does not show. That the changes are large, lasting or repeatable. Nine men is a very small group, the self-ratings are self-reports, and nobody has repeated the trial. No trial has looked at sermorelin in men under about 55.
Cognition
A 2006 trial in Neurobiology of Aging reported that six months of daily GHRH versus placebo in 89 healthy adults around age 68 was associated with better scores on several cognitive measures. The larger 2012 follow-on in Archives of Neurology used tesamorelin, a different GHRH analogue. One trial, not repeated with sermorelin itself.
Sermorelin for Men
What matters for men
Sermorelin is not a testosterone booster
Sermorelin acts on growth hormone release, a separate pituitary system from the one that drives testosterone. It does not raise testosterone and cannot replace it. Most men over 40 do not have hypogonadism, and when they do, no peptide treats it: in the European Male Ageing Study, published in the New England Journal of Medicine in 2010, only poor morning erections, low desire and erectile dysfunction had a syndromic association with low testosterone. Pepti does not prescribe or sell testosterone. More in peptides for testosterone.
Taking it alongside testosterone replacement
Men on TRT often ask about a growth hormone axis peptide, and sermorelin is often what a physician suggests to a man on testosterone who wants to change one thing gently. There is no randomised trial of sermorelin, or any compounded peptide, alongside testosterone replacement. The relevant trials gave recombinant growth hormone with testosterone to older men, and the signal to watch from them is glucose handling: in a 2002 JAMA trial, diabetes or glucose intolerance occurred in 18 growth-hormone-treated men compared with 7 not receiving growth hormone. Those trials supplied the hormone from outside, which is not what sermorelin does, but they are why glucose belongs in the conversation. List your testosterone on the intake. More in can you take peptides with testosterone.
Blood sugar
Growth hormone reduces insulin sensitivity. In the published sermorelin trials fasting glucose was unchanged, and insulin sensitivity rose in the men in the 16-week trial, but the 2018 Sexual Medicine Reviews paper noted some concern about blood glucose for the class. Diabetes or impaired glucose tolerance needs discussing at intake, and thirst or frequent urination is worth reporting.
Prostate and cancer history
Sermorelin raises growth hormone and IGF-1. No study has shown that it causes cancer in humans, and long-term cancer-incidence data for the class do not exist. A 2004 systematic review in the Lancet reported that higher circulating IGF-1 in the general population was associated with a higher risk of prostate cancer, among others; that is an observational association about lifelong natural levels, not evidence about a monitored medication. Active malignancy is a decline, and a history in remission, including prostate cancer, is a conversation with your physician and often your oncologist. See can peptides cause cancer.
Sleep apnoea comes first
Snoring, gasping at night or heavy daytime sleepiness are reasons for a sleep assessment before any peptide, because sermorelin does not treat a breathing cause of poor sleep. If sleep is the whole complaint, DSIP is aimed at it more directly, and peptides for sleep covers the options.
Fertility
Human fertility outcome data for sermorelin is absent. Unlike testosterone replacement, it does not supply a hormone that switches the testes' own signal down, but no trial has measured sperm or fertility on it. Tell your physician if you are trying to conceive. See do peptides affect fertility.
Tested sport
The 2026 WADA Prohibited List names sermorelin as a prohibited GHRH analogue, prohibited at all times. A prescription does not change that. See is sermorelin banned in sports.
Sermorelin for Men
What the evidence does not establish
- That sermorelin builds muscle or changes body composition in men in a reliable way. One small trial reported more lean mass in men; another found none.
- That it improves sleep. Measured sleep did not improve in trial conditions.
- That it raises testosterone or treats any symptom of low testosterone.
- Any trial in men under about 55.
- Long-term outcome or safety data over years of adult use; the longest placebo-controlled adult exposure is about six months.
Response varies between people, and nothing on this page is a timeline. What the trials measured and for how long is in how long does sermorelin take to work.
Sermorelin for Men
Side effects
Sermorelin has a documented side-effect profile from its approved-drug years and from the trials above. Nothing in the live research suggests it differs for men.
| How often | What is reported | What to do |
|---|---|---|
| Common | Injection-site redness, itching, a small lump | Rotate sites |
| Common | Flushing or warmth shortly after a dose | Usually settles; report it if marked |
| Common | Vivid dreams, especially with evening dosing | Report it |
| Common | Headache in the first weeks | Report it if it persists |
| Uncommon | Fluid retention, puffy hands or ankles, joint aches, stiffness on waking | Report it; it usually means the dose is above what you need |
| Uncommon | Tingling or numbness in the hands | Report it the same day |
| Stop and get help | Facial or throat swelling, widespread rash, breathing difficulty | Call 911, then tell your physician |
| Stop and call | Severe persistent headache, vision change, fainting | Same-day contact |
The middle rows are the recognised pattern of growth hormone above your requirement. The right response is a message to your care team, not pushing through and not changing the dose yourself. Sermorelin on its own is not usually associated with appetite change; the Ipamorelin + Sermorelin pairing adds a ghrelin-receptor agonist, and some people report more appetite on it. The fuller picture is in is sermorelin safe.
Sermorelin for Men
Where sermorelin stands with the FDA
Sermorelin has never been in any category of the FDA's 503A interim list. It was formerly the active ingredient of an approved product, approved in 1990 as a diagnostic and in 1997 for growth hormone deficiency in children, and discontinued in 2008. No FDA-approved sermorelin product is on the US market today. Compounded sermorelin is not FDA approved.
Sermorelin for Men
How Pepti supplies sermorelin
| Product | What is in it | Typical directions | Price |
|---|---|---|---|
| Sermorelin | 5 mL multi-dose vial, 2 mg/mL (10 mg sermorelin) | 0.25 mL (25 units) subcutaneously Monday through Friday nights | $229/mo |
| Ipamorelin + Sermorelin | 5 mL vial, 10 mg ipamorelin and 10 mg sermorelin | 0.25 mL (25 units) subcutaneously Monday through Friday nights at bedtime | $219/mo |
| CJC-1295 / Ipamorelin | 5 mL vial, 6 mg CJC-1295 and 12 mg ipamorelin | 0.25 mL (25 units) once daily Monday through Friday on an empty stomach | $239/mo |
| Tesamorelin | 5 mL vial, 10 mg tesamorelin | 0.25 mL (25 units) Monday through Friday nights at bedtime | $249/mo |
On the sermorelin vial, each 0.25 mL dose delivers 0.5 mg, and the vial holds 20 doses, about four weeks of weekday-night dosing, which is why refills run every 28 days, one vial per fill. Sermorelin is also listed as a 3 mL pre-filled Pen cartridge containing 9 mg; the product page has the details. Your physician sets your directions after reviewing your intake, and they are printed on the vial. The dosing detail is in sermorelin dosage, and how sermorelin compares with the other GHRH options is in CJC-1295 vs sermorelin and sermorelin vs tesamorelin vs ipamorelin.
Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. Vials arrive ready to use with sterile syringes and alcohol prep pads, shipped refrigerated with ice packs. Lot test results are at /quality/lab-results.
Sermorelin for Men
Where to get sermorelin prescribed
Sermorelin cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, including glucose, cancer and prostate history, any testosterone you take, your medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and side effects.
Step by step: how to get sermorelin prescribed online. What to check on any provider is in where to buy sermorelin online, and the wider picture is in peptides for men over 40. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
References
What this is based on.
References
- Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women · The Journal of clinical endocrinology and metabolism (1997) · PMID 9141536
- Vittone J, Blackman MR, Busby-Whitehead J, et al.. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men · Metabolism: clinical and experimental (1997) · PMID 9005976
- Thorner M, Rochiccioli P, Colle M, et al.. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group · Journal of Clinical Endocrinology & Metabolism (1996) · PMID 8772599
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency · BioDrugs (1999) · PMID 18031173
- Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men · Journal of Clinical Endocrinology & Metabolism (1992) · PMID 1379256
- Khorram O, Yeung M, Vu L, Yen SS. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women · Journal of Clinical Endocrinology & Metabolism (1997) · PMID 9360512
- Vitiello MV, Moe KE, Merriam GR, et al.. Growth hormone releasing hormone improves the cognition of healthy older adults · Neurobiology of Aging (2006) · PMID 16399214
- Baker LD, Barsness SM, Borson S, et al.. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial · Archives of Neurology (2012) · PMID 22869065
- Johannsson G, Touraine P, Feldt-Rasmussen U, Pico A, Vila G et al.. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients · J Clin Endocrinol Metab (2022) · PMID 35368070
- Münzer T, Rosen CJ, Harman SM et al.. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men · Am J Physiol Endocrinol Metab (2006) · PMID 16390864
- Roelfsema F, Yang RJ, Takahashi PY et al.. Aromatized Estrogens Amplify Nocturnal Growth Hormone Secretion in Testosterone-Replaced Older Hypogonadal Men · J Clin Endocrinol Metab (2018) · PMID 30032193
- Merriam GR, Schwartz RS, Vitiello MV. Growth hormone-releasing hormone and growth hormone secretagogues in normal aging · Endocrine (2003) · PMID 14610297
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Sermorelin for Men, answered.
It reliably raised nocturnal growth hormone in trials in older men, and raised IGF-1 when dosed often enough. In one 16-week trial, men also had more lean mass and better insulin sensitivity; a six-week trial in eleven men found no change in body composition.
The research describes a rise in your own growth hormone and IGF-1, and in one small trial more lean mass, better insulin sensitivity, thicker skin and better self-rated well-being and libido in men. Sleep, recovery and energy are reported by patients but have not been measured as trial outcomes.
No. It acts on growth hormone release, a separate system. It is not a testosterone booster and cannot replace testosterone.
Many men on testosterone ask about it, and no interaction has been described, but no trial has tested the combination. List your testosterone on the intake; glucose handling is the thing physicians watch when both axes are engaged.
Not reliably in the trials. Lean mass rose in men in one 16-week trial of nine men and did not change in a six-week trial of eleven. No trial has looked at men under about 55.
Many people report deeper sleep, and the dose is given at bedtime for that reason. Under trial conditions, a short-acting GHRH did not improve measured sleep, and sleep quality was unchanged in the 1997 trial.
It is aimed at the age-related shrinking of the growth hormone pulse, and most of its adult trials were in men over 55. Whether it suits you depends on your glucose, cancer history and what you want help with; see peptides for men over 40.
There is no human fertility data. Unlike testosterone replacement, it does not supply a hormone that suppresses the testes' own signal, but no trial has measured sperm on it. Tell your physician if you are trying to conceive.
No study has shown sermorelin causes prostate cancer. Higher natural IGF-1 has been associated with prostate cancer risk in observational research, so active cancer is a decline and a history is discussed with your physician first.
Most commonly injection-site reactions, flushing, vivid dreams and headache. Less commonly fluid retention, joint aches and tingling hands, which usually mean the dose is higher than needed and should be reported to your care team.
At Pepti, sermorelin is $229 a month and Ipamorelin + Sermorelin is $219 a month, all-in, covering medication, physician review, refill management and shipping.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.



